Published in J Clin Psychiatry on July 01, 2014
Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease | NCT01055392
Renal toxicity of long-term lithium treatment for mild cognitive impairment. J Clin Psychiatry (2015) 1.08
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Lithium nephrotoxicity. Int J Bipolar Disord (2015) 0.85
Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study. ACS Chem Neurosci (2014) 0.81
Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord (2016) 0.77
Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord (2017) 0.75
Drs Aprahamian and Forlenza reply. J Clin Psychiatry (2015) 0.75
Acute renal and neurotoxicity in older lithium users: How can we manage and prevent these events in patients with late-life mood disorders? J Psychiatry Neurosci (2015) 0.75
An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal function. Int J Bipolar Disord (2017) 0.75
Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2015) 0.75
Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice? Clin Drug Investig (2017) 0.75
Drug information update. Lithium and chronic kidney disease: debates and dilemmas. BJPsych Bull (2017) 0.75
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry (2011) 2.20
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry (2005) 1.98
Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry (2007) 1.95
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement (2011) 1.87
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res (2008) 1.84
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry (2012) 1.69
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry (2012) 1.55
Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiol Aging (2009) 1.46
Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 1.23
Hydrazone-based switches, metallo-assemblies and sensors. Chem Soc Rev (2014) 1.23
Multifocal slow potential generation revealed by high-resolution EEG and current density reconstruction. Int J Psychophysiol (2002) 1.17
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry (2005) 1.17
Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. Am J Psychiatry (2005) 1.16
The generators of slow potentials obtained during verbal, pictorial and spatial tasks. Int J Psychophysiol (2003) 1.16
A switching cascade of hydrazone-based rotary switches through coordination-coupled proton relays. Nat Chem (2012) 1.11
Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis. Eur Arch Psychiatry Clin Neurosci (2006) 1.11
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm (Vienna) (2008) 1.10
Does lithium prevent Alzheimer's disease? Drugs Aging (2012) 1.10
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia. World J Biol Psychiatry (2006) 1.10
Reduced cortical folding in schizophrenia: an MRI morphometric study. Am J Psychiatry (2003) 1.08
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res (2008) 1.08
Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol (2008) 1.05
Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep (2011) 1.05
Voxel-based morphometry in Alzheimer's disease. Expert Rev Neurother (2008) 1.04
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry (2009) 1.04
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry (2004) 1.00
Mortality from dementia in a community-dwelling Brazilian population. Int J Geriatr Psychiatry (2005) 0.99
Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res (2003) 0.99
Reduced serum nerve growth factor in patients with late-life depression. Am J Geriatr Psychiatry (2013) 0.98
Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry (2010) 0.97
Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr (2008) 0.97
White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies. Expert Rev Neurother (2013) 0.96
Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuropsychol Soc (2010) 0.96
Switching around two axles: controlling the configuration and conformation of a hydrazone-based switch. Org Lett (2010) 0.96
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo) (2011) 0.96
Alzheimer's disease. Subcell Biochem (2012) 0.95
Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease. Neuromolecular Med (2012) 0.93
Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett (2011) 0.93
Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med (2010) 0.93
Neuropsychiatric symptoms in the prodromal stages of dementia. Curr Opin Psychiatry (2014) 0.93
Isomerization mechanism in hydrazone-based rotary switches: lateral shift, rotation, or tautomerization? J Am Chem Soc (2011) 0.93
Toward electrochemically controllable tristable three-station [2]catenanes. Chem Asian J (2007) 0.92
Reduced serum levels of adiponectin in elderly patients with major depression. J Psychiatr Res (2012) 0.92
Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine. J Clin Psychiatry (2007) 0.90
CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. Int J Geriatr Psychiatry (2008) 0.89
A pH activated configurational rotary switch: controlling the E/Z isomerization in hydrazones. J Am Chem Soc (2009) 0.89
Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. J Psychiatr Res (2010) 0.89
Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Rev Bras Psiquiatr (2010) 0.88
Outcomes for Latin American versus White patients suffering from acute mania in a randomized, double-blind trial comparing olanzapine and haloperidol. J Clin Psychopharmacol (2007) 0.88
Visible light switching of a BF2-coordinated azo compound. J Am Chem Soc (2012) 0.87
Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia. Rev Bras Psiquiatr (2013) 0.87
Circulating Glial-derived neurotrophic factor is reduced in late-life depression. J Psychiatr Res (2011) 0.86
Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability. Prostaglandins Leukot Essent Fatty Acids (2006) 0.86
Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berl) (2008) 0.86
Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology (Berl) (2008) 0.86
Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Res (2008) 0.86
Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory. Psychopharmacology (Berl) (2005) 0.85
The effects of alcohol mixed with energy drinks (AmED) on traffic behaviors among Brazilian college students: a national survey. Traffic Inj Prev (2013) 0.85
Switching through coordination-coupled proton transfer. Angew Chem Int Ed Engl (2011) 0.85
Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry (2010) 0.85
Functionally rigid bistable [2]rotaxanes. J Am Chem Soc (2007) 0.84
Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains. Int J Geriatr Psychiatry (2011) 0.84
Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study. Schizophr Res (2004) 0.84
Effects of a multidisciplinary cognitive rehabilitation program for patients with mild Alzheimer's disease. Clinics (Sao Paulo) (2011) 0.84
Complex slow potential generators in a simplified attention paradigm. Int J Psychophysiol (2005) 0.84
Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology (2012) 0.84
Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2007) 0.84
Loss of interest, depressed mood and impact on the quality of life: cross-sectional survey. BMC Public Health (2011) 0.83
The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil. Int Psychogeriatr (2005) 0.83
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.83
Cognitive training increases platelet PLA2 activity in healthy elderly subjects. Prostaglandins Leukot Essent Fatty Acids (2008) 0.82
New treatment strategies for Alzheimer's disease: is there a hope? Indian J Med Res (2013) 0.82
Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease. PLoS One (2012) 0.82
Childhood meningitis increases the risk for adult schizophrenia. World J Biol Psychiatry (2005) 0.81
Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry. J Sep Sci (2008) 0.81
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis. World J Biol Psychiatry (2014) 0.81
Inhibition of cPLA2 and sPLA2 activities in primary cultures of rat cortical neurons by Centella asiatica water extract. Nat Prod Commun (2012) 0.81
Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl) (2014) 0.81
Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly. Clinics (Sao Paulo) (2009) 0.81
Inhibition of platelet phospholipase A2 activity by catuaba extract suggests antiinflammatory properties. Phytother Res (2004) 0.81
Leukocyte mitochondrial DNA copy number in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.81
Fullerene Anions: Unusual Charge Distribution in C(70)(6-) We are grateful to the U.S.-Israel Binational Science Foundation for financial support for this work. Angew Chem Int Ed Engl (2001) 0.81
Kinetic and thermodynamic approaches for the efficient formation of mechanical bonds. Acc Chem Res (2008) 0.81
Negative expressed emotion best discriminates families with bipolar disorder children. J Affect Disord (2012) 0.80
Blue-colored donor-acceptor [2]rotaxane. Org Lett (2007) 0.80
Simple hydrazone building blocks for complicated functional materials. Acc Chem Res (2014) 0.80
Acute hormonal changes after IV citalopram and treatment response in OCD. Psychopharmacology (Berl) (2007) 0.80